{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-336762","form_type":"8-K","ticker":"CLYM","cik":"0001768446","company_name":"Climb Bio, Inc.","filed_at":"2026-08-06T11:35:16+00:00","discovered_at":"2026-08-06T11:40:00.273510+00:00","generated_at":"2026-08-06T11:40:31.855714+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Climb Bio Q2 2026 cash $239.2M; pipeline advances with CLYM116 Phase 2 initiation in Q3","bullets":["Cash, cash equivalents, and marketable securities $239.2M as of June 30, 2026; raised ~$110M in private placement in April 2026, extending runway into H2 2028.","R&D expenses $9.7M (vs $6.6M YoY); G&A $5.6M (vs $4.1M YoY); other income $1.9M.","CLYM116 Phase 1 data to be presented at R&D Spotlight on Sept 3, 2026; Phase 2 trial in IgAN to start dosing in Q3 2026.","Budoprutug data expected from pMN, ITP, and SLE studies in Q4 2026; SC formulation data positive.","Appointed Breanna O'Reilly, Ph.D., to Board of Directors in June 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-336762","json":"https://secwatch.observer/filing/0001193125-26-336762.json","markdown":"https://secwatch.observer/filing/0001193125-26-336762.md","text":"https://secwatch.observer/filing/0001193125-26-336762.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1768446/000119312526336762/0001193125-26-336762-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1768446/000119312526336762/clym-20260806.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-06T11:40:31.855714+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}